Eli Lilly’s experimental Alzheimer’s treatment failed to slow the progression of the neurodegenerative disease, yet another setback to drugmakers and researchers who continue to seek a way to treat one of the most feared ailments in the world. The shares fell as much as 14%.

US pharmaceutical company Eli Lilly is to invest €35m in a new hi-tech manufacturing facility at its Kinsale campus in County Cork.